Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7434-7440

  Itoh, Saotomo ^a   Hattori, Takayuki ^a   Hayashi, Hidetoshi ^a   Mizutani, Yukiko ^a   Todo, Makoto ^a   Takii, Takemasa ^a   Yang, De ^a   Lee, John C ^b   Matsufuji, Senya ^c   Murakami, Yasuko ^c   Chiba, Taku ^a   Onozaki, Kikuo ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b GLAXOSMITHKLINE   (United Kingdom)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; ORNITHINE DECARBOXYLASE;

ARTICLE; CALCIUM TRANSPORT; CELL PROLIFERATION; DECARBOXYLATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME SUBSTRATE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; PLEIOTROPY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; GROWTH INHIBITORS; HUMANS; IMIDAZOLES; INTERLEUKIN-1; INTERLEUKIN-6; INTRACELLULAR FLUID; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASES; ORNITHINE DECARBOXYLASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYAMINES; PROTEINS; PYRIDINES; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033564934     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Dinarello, C. A. 1996. Biological basis for interleukin-1 in disease. Blood 87: 2095.
2. Gery, I., R. K. Gershon, and B. H. Waksman. 1972. Potentiation of the T-lymphocytes response to mitogens. I. The responding cell. J. Exp. Med. 136:128.
3. Freedman, A. S., G. Freeman, J. Whitman, J. Segil, J. Daley, and J. M. Nadler. 1988. Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation. J. Immunol. 141:3398.
4. Schmidt, J. A., S. B. Mizel, D. Cohen, and I. Green. 1982. Interleukin 1, a potential regulator of fibroblast proliferation. J. Immunol. 128:2177.
5. Reimers, J. I, H. U. Andersen, D. Mauricio, F. Pociot, A. E. Karlsen, J. S. Petersen, T. Mandrup-Poulsen, and J. Nerup. 1996. Strain-dependent differences in sensitivity of rat β cells to interleukin 1β in vitro and in vivo: association with islet nitric oxide synthesis. Diabetes 45:771.
6. Maier, J. A., P. Voulalas, D. Roeder, and T. Maciag. 1990. Extension of the life-span of human endothelial cells by an interleukin-1α antisense oligomer. Science 249:1570.
7. Onozaki, K., T. Tamatani, T. Hashimoto, and K. Matsushima. 1987. Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1. Cancer Res. 47:2397.
8. Onozaki, K., K. Matsushima, B. B. Aggarwal, and J. J. Oppenheim. 1985. Human interleukin 1 is a cytocidal factor for several tumor cell lines. J. Immunol. 135:3962.
9. Morinaga, Y., H Suzuki, F. Takatsuki, Y. Akiyama, T. Taniyama, K. Matsushima, and K. Onozaki. 1989. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. J. Immunol. 143:3538.
10. Endo, Y., K. Matsushima, K. Onozaki, and J. J. Oppenheim. 1988. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor. J. Immunol. 141:2342.
11. 1 arrest of a human melanoma cell line by IL-1. Biochem. Biophys. Res. Commun. 173:186.
12. Tabor, C. W., and H. Tabor. 1984. Polyamines. Annu. Rev. Biochem. 53:749.
13. Hayashi, S. 1989. Ornithine Decarboxylase: Biology, Enzymology and Molecular Genetics. Pergamon, New York. pp. 35-45.
14. Seidenfeld, J. 1985. Effects of difluoromethylornithine on proliferation, polyamine content and plating efficiency of cultured human carcinoma cells. Cancer Chemother. Pharmacol. 15:196.
15. Heby, O., L. J. Marton, C. B. Wilson, and H. M. Martinez. 1975. Polyamines: a high correlation with cell replication. FEBS Lett. 50:1.
16. Yang, D., H. Hayashi, Y. Hiyama, T. Takii, and K. Onozaki. 1996. Transfection of human melanoma cells with type I interleukin-1 (IL-1) receptor cDNA rendered them IL-1 responsive and revealed the importance of ODC activity down-regulation in IL-1 induced growth inhibition. J. Biochem. (Tokyo) 118:802.
17. Hayashi, S., Y. Murakami, and S. Matsufuji. 1996. Omithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem. Sci. 21:27.
18. Yang, D., H. Hayashi, T. Takii, Y. Mizutani, Y. Inukai, and K. Onozaki. 1997. Interleukin-1-induced growth inhibition of human melanoma cells: interleukin-1-induced antizyme expression is responsible for ornithine decarboxylase activity down-regulation. J. Biol. Chem. 272:3376.
19. Cano, E., and L. C. Mahadevan. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:117.
20. Galcheva-Gargova, Z., B. Derijard, I. H. Wu, and R. J. Davis. 1994. An osmosensing signal transduction pathway in mammalian cells. Science 265:806.
21. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-jun kinases. Nature 369:156.
22. Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420.
23. Derijard, B., J. Raingeaud, T. Barrett, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682.
24. Han, J., J. D. Lee, Y. Jiang, Z. Li, L. Feng, and R. J. Ulevitch. 1996. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 271:2886.
25. Matsuda, S., T. Moriguchi, S. Koyasu, and E. Nishida. 1998. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273:12378.
26. Cohen, P. 1997. The search for physiological substances of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7:353.
27. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. R. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027.
28. Wang, X. Z., and D. Ron. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP(GADD 153) by p38 MAP kinase. Science 272:1347.
29. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, R. J. Heys, S. W. Landvatter, et al. 1994. A protein kinase is involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
30. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229.
31. Araki, M., T. Yano, H. Hayashi, T. Takii, K. Suzuki, and K. Onozaki. 1994. Resistance to the anti-proliferative effect of IL-1 on human melanoma cell line is associated with endogenous production of IL-1 and IL-6. Int. J. Cancer 56:275.
32. Stokoe, D., D. G. Campbell, S. Nakielny, H. Hidaka, S. J. Leevers, C. Marshall, and P. Cohen. 1992. MAPKAP kinase-2: a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 11:3985.
33. Ruff, M. R., and G. E. Gifford. 1980. Purification and physicochemical characterization of rabbit tumor necrosis factor. J. Immunol. 125:1671.
34. Matsuda, T., T. Hirano, and T. Kishimoto. 1988. Establishment of an interleukin 6 (IL-6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur. J. Immunol. 18:951-956.
35. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods 65:55.
36. Seely, J. E., and A. E. Pegg. 1983. Ornithine decarboxylase (mouse kidney). Methods Enzymol. 94:158.
37. Seiler, N. 1983. Liquid Chromatographic methods for assaying polyamines using prechromatographic derivatization. Methods Enzymol. 94:10.
38. Chomezynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium. Anal. Biochem. 162:156.
39. Itoh, S., H. Hayashi, D. Yang, T. Takii, and K. Onozaki. 1997. Acquired resistance to the anti-proliferative effect of interleukin-1 and interleukin-6 is a recessive phenotype in A375 human melanoma cells. Melanoma Res. 7:455.
40. Choi, A. M., J. Fargnoli, S. G. Carlson, and N. J. Holbrook. 1992. Cell growth inhibition by prostaglandin A2 results in elevated expression of gadd 153 mRNA. Exp. Cell Res. 199:85.
41. Lavoie, J. N., G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated positively by the p42/p44 MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608.
42. Jiang, Y., H. Gram, M. Zhao, L. New, J. Gu, L. Feng, F. D. Padova, R. J. Ulevitch, and J. Han. 1997. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinase, p38δ. J. Biol. Chem. 272:30122.